JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,000 | -57.1% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $14,000 | -17.6% | 2,000 | 0.0% | 0.00% | – |
Q4 2021 | $17,000 | +13.3% | 2,000 | 0.0% | 0.00% | – |
Q3 2021 | $15,000 | +7.1% | 2,000 | 0.0% | 0.00% | – |
Q2 2021 | $14,000 | -33.3% | 2,000 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $21,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |